BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34065085)

  • 1. Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.
    Ferreira KP; de Almeida BC; Dos Anjos LG; Baiocchi G; Soares FA; Rocha RM; Baracat EC; Dobroff AS; Carvalho KC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
    Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
    Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROCK1 as a novel prognostic marker in vulvar cancer.
    Akagi EM; Lavorato-Rocha AM; Maia Bde M; Rodrigues IS; Carvalho KC; Stiepcich MM; Baiocchi G; Sato-Kuwabara Y; Rogatto SR; Soares FA; Rocha RM
    BMC Cancer; 2014 Nov; 14():822. PubMed ID: 25380619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.
    Wang J; Wu Q; Zhang LH; Zhao YX; Wu X
    Tumour Biol; 2016 Mar; 37(3):2879-90. PubMed ID: 26409448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
    Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM
    Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
    Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
    Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.
    Wu Q; Jiang Y; Cui S; Wang Y; Wu X
    Oncol Rep; 2016 May; 35(5):2743-54. PubMed ID: 26936386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
    Clancy AA; Spaans JN; Weberpals JI
    Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p.
    Yang X; Wu X
    Oncol Rep; 2016 Jan; 35(1):398-408. PubMed ID: 26498065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
    Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
    J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
    Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
    Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Retinoic Acid Receptor β Gene With Onset and Progression of Lichen Sclerosus-Associated Vulvar Squamous Cell Carcinoma.
    Rotondo JC; Borghi A; Selvatici R; Mazzoni E; Bononi I; Corazza M; Kussini J; Montinari E; Gafà R; Tognon M; Martini F
    JAMA Dermatol; 2018 Jul; 154(7):819-823. PubMed ID: 29898214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.
    Yang S; Zhao Y; Wang L; Liu C; Lu Y; Fang Z; Shi H; Zhang W; Wu X
    Oncol Rep; 2019 Nov; 42(5):1689-1698. PubMed ID: 31545465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
    McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
    Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma.
    Boujelbene N; Ben Yahia H; Babay W; Gadria S; Zemni I; Azaiez H; Dhouioui S; Zidi N; Mchiri R; Mrad K; Ouzari HI; Charfi L; Zidi I
    HLA; 2019 Jul; 94(1):11-24. PubMed ID: 30907063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.
    Larsson GL; Helenius G; Andersson S; Elgh F; Sorbe B; Karlsson MG
    Int J Gynecol Cancer; 2012 Oct; 22(8):1413-9. PubMed ID: 23013732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.
    Wang Z; Førsund MS; Trope CG; Nesland JM; Holm R; Slipicevic A
    Cancer Med; 2018 Aug; 7(8):3955-3964. PubMed ID: 29963769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target.
    Condic M; Egger EK; Klümper N; Kristiansen G; Mustea A; Thiesler T; Ralser DJ
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8235-8241. PubMed ID: 37067548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.